Best Practices

The VA Geriatric Scholars Program

Author and Disclosure Information

 

Through the GSP, an estimated 309,671 older veterans are now receiving care from clinicians who have developed additional skills in geriatrics. This fall, the GSP will be welcoming a new class of 60 learners, expanding the scope of the program and reaching veterans in more communities.

Acknowledgements
The Geriatric Scholars Program is a collaboration of 10 Geriatric Research Education and Clinical Centers (GRECCs) and the VA Office of Geriatrics and Extended Care (GEC). The contributions of all past and present collaborators are gratefully acknowledged, including Judith Howe, PhD (Bronx GRECC); Carol Callaway-Lane, DNP (Tennessee Valley GRECC); Terri Huh, PhD (Palo Alto GRECC); Steven Barzci, MD (Madison GRECC); Kathy Horvath, PhD, RN, and Scott Trudeau, PhD, PT (New England GRECC); Sandra Sanchez-Reilly, MD (San Antonio GRECC); Connie Bales, PhD, RD (Durham GRECC); Ronni Chernoff, PhD, RD, Kim Garner, MD, and Sheila Cox Sullivan, PhD, RN (Little Rock GRECC); Stephen Thielke, MD (Puget Sound GRECC); Nina Tumosa, PhD (currently at the U.S. Health Resources and Services Administration); and Kenneth Shay, DMD (Office GEC). We gratefully acknowledge and appreciate the staff at the VA Greater Los Angeles Healthcare System GRECC program hub site whose contributions “behind the scene” make this multi-faceted program possible: Luis Melendez, MPA, MS (program administrator); Joseph Douglas (special projects manager); Timothy Gardner, MBA (program analyst); Beth Creekmur, MA (budget analyst); and Diane Lee, MSW (program support staff).

Author disclosures
The author reports no actual or potential conflicts of interest with regard to this article.

Disclaimer
The opinions expressed herein are those of the author and do not necessarily reflect those of
Federal Practitioner, Frontline Medical Communications Inc., the U.S. Government, or any of its agencies. This article may discuss unlabeled or investigational use of certain drugs. Please review complete prescribing information for specific drugs or drug combinations—including indications, contraindications, warnings, and adverse effects—before administering pharmacologic therapy to patients.

Pages

Recommended Reading

HHS Grants Expand Home Visiting
Federal Practitioner
DoD and YMCA Renew Partnership
Federal Practitioner
Understanding the Corporate Data Warehouse
Federal Practitioner
Sharing Alzheimer Research, Faster
Federal Practitioner
Family Support Can Prevent Postdeployment Suicide
Federal Practitioner
Profitably Reining in Health Care Fraud
Federal Practitioner
Nivolumab Approved for Expanded Indication
Federal Practitioner
Protecting Sensory Health
Federal Practitioner
VHA Under Harsh Criticism From OIG, GAO
Federal Practitioner
Advances in Radiation Therapy for Prostate Cancer
Federal Practitioner

Related Articles